These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10855583)

  • 1. Blood donation by healthy individuals with haemochromatosis.
    Blacklock HA; Dewse M; Bollard C; Hudson P; Barnhill D; Jackson S
    N Z Med J; 2000 Mar; 113(1105):77-8. PubMed ID: 10855583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phlebotomy patterns in haemochromatosis patients and their contribution to the blood supply.
    Walkden D; Badami K
    N Z Med J; 2012 Jul; 125(1358):29-34. PubMed ID: 22864154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demanding pure motives for donation: the moral acceptability of blood donations by haemochromatosis patients.
    Pennings G
    J Med Ethics; 2005 Feb; 31(2):69-72. PubMed ID: 15681668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Throwing out good blood. Why the Red Cross cries 'crisis'--and tosses out so much.
    Hawkins D
    US News World Rep; 1997 Sep; 123(8):26, 31. PubMed ID: 10174194
    [No Abstract]   [Full Text] [Related]  

  • 5. Worldwide policies on haemochromatosis and blood donation: a survey among blood services.
    Pauwels NS; De Buck E; Compernolle V; Vandekerckhove P
    Vox Sang; 2013 Aug; 105(2):121-8. PubMed ID: 23663183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do patient-related blood donors represent a threat to the safety of the blood supply?
    Pereira A; Sanz C; Tàssies D; Ramírez B
    Haematologica; 2002 Apr; 87(4):427-33. PubMed ID: 11940488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Facilitation of blood donation amongst haemochromatosis patients.
    Marrow B; Clarkson J; Chapman CE; Masson S
    Transfus Med; 2015 Aug; 25(4):239-42. PubMed ID: 25800958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemochromatosis: evaluating the effectiveness of a novel patient self-management approach to venesection as blood donation.
    Mishra S; Sim D; Flanagan P
    N Z Med J; 2017 Jun; 130(1457):26-33. PubMed ID: 28617785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemochromatosis patients as voluntary blood donors.
    Power TE; Adams PC
    Can J Gastroenterol; 2004 Jun; 18(6):393-6. PubMed ID: 15190395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phlebotomy, blood donation, and hereditary hemochromatosis.
    Conry-Cantilena C
    Transfus Med Rev; 2001 Apr; 15(2):136-43. PubMed ID: 11309733
    [No Abstract]   [Full Text] [Related]  

  • 11. Pattern of care of blood donors with early-uncomplicated hereditary haemochromatosis in a Swiss blood donation centre.
    Stefashyna O; Stern M; Infanti L; Holbro A; Tichelli A; Buser A; O'Meara A
    Vox Sang; 2014 Feb; 106(2):111-7. PubMed ID: 23992555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Worth the cost?
    Ortolon K
    Tex Med; 2004 Jan; 100(1):43-5. PubMed ID: 15146771
    [No Abstract]   [Full Text] [Related]  

  • 13. Hemochromatosis subjects as allogeneic blood donors: a prospective study.
    Leitman SF; Browning JN; Yau YY; Mason G; Klein HG; Conry-Cantilena C; Bolan CD
    Transfusion; 2003 Nov; 43(11):1538-44. PubMed ID: 14617312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient compliance with phlebotomy therapy for iron overload associated with hemochromatosis.
    Hicken BL; Tucker DC; Barton JC
    Am J Gastroenterol; 2003 Sep; 98(9):2072-7. PubMed ID: 14499790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood donation centers: new partners in health care access management.
    Orchard W
    NAHAM Manage J; 1992; 17(3):12-3. PubMed ID: 10117164
    [No Abstract]   [Full Text] [Related]  

  • 16. Cost-effectiveness of FDA variance for blood collection from individuals with hereditary hemochromatosis at a 398-bed hospital-based donor center.
    Gribble DM; Chaffin DJ; Bryant BJ
    Immunohematology; 2009; 25(4):170-3. PubMed ID: 20406025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor blood procurement and utilisation at the University of Benin Teaching Hospital, Benin City.
    Enosolease ME; Imarengiaye CO; Awodu OA
    Afr J Reprod Health; 2004 Aug; 8(2):59-63. PubMed ID: 15623119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The development of West Nile virus safety policies by Canadian blood services: guiding principles and a comparison between Canada and the United States.
    Vamvakas EC; Kleinman S; Hume H; Sher GD
    Transfus Med Rev; 2006 Apr; 20(2):97-109. PubMed ID: 16565024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donors' blood group declaration before donation can be used as a tool for electronic crossmatching.
    Arslan O
    Transfus Med; 2005 Dec; 15(6):487-92. PubMed ID: 16359420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The median whole-blood donation time in the best-case scenario: findings at one blood center.
    Newman BH; Patel BR
    Transfusion; 2006 Jan; 46(1):99-104. PubMed ID: 16398737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.